The funds will be used to support BrainQ's multicenter pivotal trial using its tech to aid stroke patients in select hospitals across the US.

BrainQ is set to present its findings next month from its latest randomized controlled clinical trial for ischemic stroke patients.

BrainsGate’s therapy involves a less than five minute procedure in which a neurostimulator implant is injected into an existing canal.

Aidoc, the Israeli startup that developed AI-powered software that analyzes medical images, announced Monday that the US Food and Drug Administration (FDA) has cleared the company’s AI solution for flagging large-vessel occlusion (LVO) in head CTA scans. Large-vessel occlusion are defined as blockages of the proximal intracranial anterior and posterior circulation and account for approximately […]